Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,450 total articles
FreightCar America, Inc. announced its addition to the Russell 2000® and Russell 3000® indexes as of June 29, 2026, reflecting the company's growth and strengthening business. Inclusion in these widely followed benchmarks enhances its visibility among institutional investors and supports its goal of creating long-term shareholder value.
Twin Disc, Inc. has been added to the Russell 2000 and Russell 3000 indexes, marking a significant milestone for the company. This inclusion reflects Twin Disc’s progress in strengthening its business and strategy execution, positioning it for long-term shareholder value. The Russell indexes are key benchmarks used by investors, potentially increas…
FuelCell Energy announced a $49 million financing approval by the U.S. Export-Import Bank to support export and delivery of fuel cell systems to South Korea. This financing will enable FuelCell Energy to expand its global clean energy footprint, support domestic manufacturing, and scale up production capabilities for international markets.
Tonix Pharmaceuticals announced the first patient enrollment in the Phase 2 HORIZON study evaluating TNX-102 SL as a first-line monotherapy for major depressive disorder (MDD). TNX-102 SL, already FDA-approved for fibromyalgia, targets sleep quality disturbances associated with MDD. This randomized, placebo-controlled trial will assess efficacy usi…
Dyadic International, a US-based biotechnology company (Nasdaq: DYAI), announced that the Japan Patent Office has approved claims for its proprietary Thermothelomyces heterothallica recombinant protein expression technology, enhancing its IP portfolio. The company is also expanding its business development activities in Japan, partnering with Intra…
Martin Marietta Materials, Inc. has announced a definitive agreement to combine with Lhoist North America for $13.5 billion in cash and stock, aiming to become the leading lime and limestone producer in the U.S. The transaction, expected to close in the second half of 2026 pending regulatory approvals, enhances Martin Marietta's exposure to critica…
Flash Sports & Media Holdings, Inc. (NASDAQ: FLZH) announced the schedule for the sixth edition of the Lanka Premier League (LPL) 2026, running July 17 to August 8. The season features a strong player lineup from around the world, expanded Sinhala-language commentary, and aims to deepen the league's connection with Sri Lankan fans and global audien…
Keel Infrastructure Corp., a developer and owner of digital and energy infrastructure for high-performance computing including AI, has been added to the Russell 3000® Index effective June 29, 2026. This inclusion recognizes Keel's strategic growth in U.S. digital and energy infrastructure sectors and is expected to enhance investor visibility and a…
Gilat Satellite Networks announced receipt of $43 million in additional orders for its Sidewinder electronically steered antenna terminals from a major in-flight connectivity provider. Deliveries will occur over the next 18 months, reflecting strong demand for high-performance, scalable satellite connectivity solutions in the aviation sector. The S…
IREN Limited has been officially added to the Russell 1000 Index following the FTSE Russell Indexes reconstitution. This inclusion reflects the company's growth in its U.S. operations and customer base, highlighting its position among the largest U.S. companies by market capitalization. IREN is a vertically integrated AI Cloud provider with a stron…
Bitdeer Technologies Group announced its subsidiary, Tydal Data Center AS, has signed a colocation lease agreement for its AI data center in Tydal, Norway. The lease is subject to certain conditions before becoming effective, and detailed terms and impacts will be disclosed once finalized. This marks a strategic move in Bitdeer's global AI infrastr…
NovaBridge Biosciences, a clinical-stage biopharmaceutical company, appointed Dr. Srishti Gupta as its new Chief Executive Officer effective July 1, 2026. Dr. Gupta brings extensive leadership experience in biopharmaceuticals and global health. She will focus on advancing the company's lead candidates, givastomig and VIS-101, toward regulatory regi…
High Roller Technologies, Inc., a U.S.-based online gaming and prediction markets company, announced its inclusion in the Russell Microcap Index effective June 26, 2026. This inclusion is expected to increase the company's visibility among institutional investors and index-tracking funds, potentially boosting investor interest and liquidity. The Ru…
NN, Inc. announced substantial new awards for its liquid-cooled products used in NVIDIA AI data center racks, significantly expanding its data center business which is its second-largest segment. The company plans to triple the size of its liquid cooling product line, adding 47 new CNC machines at its Wuxi, China facility to meet full pre-sold prod…
Rocket Lab Corporation announced it will acquire Iridium Communications Inc. for approximately $8 billion in a cash and stock transaction. The merger combines Rocket Lab's launch and manufacturing expertise with Iridium's global satellite network and L-band spectrum, creating an integrated space company capable of designing, building, launching, an…
Aurora Mobile Limited announced the launch of EngageLab's Silent Auth, a new passwordless authentication technology designed to complement existing SMS OTP services. Silent Auth enhances identity verification for high-risk transactions by verifying user identity silently and securely, improving conversion rates, and ensuring compliance with global …
Relmada Therapeutics, a clinical-stage biotech company focused on oncology and CNS therapies, announced it has been added to the Russell 2000 and Russell 3000 Indexes following the June 2026 reconstitution. This inclusion reflects the company's progress, supported by robust clinical data for its lead candidate NDV-01 and a strong financial position…
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, announced its inclusion in the Russell 2000 and Russell 3000 indexes as part of the 2026 Russell reconstitution. The company plans to initiate its U.S. Phase 3 clinical trial for denifanstat, a novel oral treatment for moderate to severe acne, expected to start in the second half…
Agios Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in rare diseases, will hold a conference call and webcast on July 30, 2026, at 8:00 a.m. ET to report its second quarter 2026 financial results and business highlights. The event will be accessible via the company's investor website, with a replay available afterward.
Satellos Bioscience announced that the FDA has granted Fast Track designation to its investigational drug, SAT-3247, for the treatment of Duchenne Muscular Dystrophy (DMD). This designation, along with previous Orphan Drug and Rare Pediatric Disease recognitions, is intended to expedite the development and review process of SAT-3247. The company is…
Dianthus Therapeutics announced the initiation of the global Phase 3 EMERGE trial testing claseprubart, an investigational monoclonal antibody targeting the classical complement pathway, in acetylcholine receptor antibody positive generalized Myasthenia Gravis patients. This follows promising Phase 2 results showing rapid and significant symptom im…
Kirby Corporation, the largest domestic tank barge operator in the US, announced the date and details for its 2026 second quarter earnings release and webcast. The company will report results on July 29, 2026, followed by a webcasted earnings conference call. Financial and operational information will be made available prior to the call.
BioCryst Pharmaceuticals announces a strategic shift from internal discovery programs to external innovation partnerships to accelerate its rare disease pipeline growth. The company will discontinue internal discovery efforts and close its Birmingham research facility by the end of 2026. BioCryst has completed enrollment in the pivotal Phase 3 stud…
Biogen announced it will showcase new data on its Alzheimer's disease portfolio at the AAIC 2026 conference, including Phase 2 results from the CELIA study evaluating diranersen, an investigational tau-targeting antisense oligonucleotide, and updated analyses on lecanemab, addressing amyloid and tau pathologies. The data underscore Biogen's leaders…
Golar LNG Limited announced that it will release its second quarter 2026 financial results before market open on Thursday, August 13, 2026. A webcast presentation will be held at 8:00 am Eastern Time followed by a Q&A session accessible to sell-side analysts. The company provides detailed instructions for accessing the live webcast and teleconferen…
